ОПРЕДЕЛЕНИЕ СВОБОДНОЙ ЭМБРИОНАЛЬНОЙ ДНК В ПЛАЗМЕ КРОВИ БЕРЕМЕННЫХ ДЛЯ НЕИНВАЗИВНОЙ ПРЕНАТАЛЬНОЙ ГЕНЕТИЧЕСКОЙ ДИАГНОСТИКИ
- Авторы: ТЕТРУАШВИЛИ Н.К.1, ФЕДОРОВА Н.И.1, ФАЙЗУЛЛИН Л.З.1, КАРНАУХОВ В.Н.1
-
Учреждения:
- ФГБУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития России
- Выпуск: № 6 (2012)
- Страницы: 4-8
- Раздел: Статьи
- URL: https://journals.eco-vector.com/0300-9092/article/view/246776
- ID: 246776
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Ключевые слова
Полный текст
Об авторах
Нана Картлосовна ТЕТРУАШВИЛИ
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития России
Email: tetrauly@mail.ru
доктор медицинских наук, профессор, руководитель 2-го отделения акушерского патологии беременности
Наталья Игоревна ФЕДОРОВА
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития России
Email: natasha_fedorova@mail.ru
врач 2-го отделения акушерского патологии беременности
Леонид Закиевич ФАЙЗУЛЛИН
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития России
Email: lfaizullin@mail.ru
кандидат биологических наук, ведущий научный сотрудник лаборатории молекулярно-генетических методов
Виталий Николаевич КАРНАУХОВ
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития Россиимладший научный сотрудник лаборатории молекулярно-генетических методов
Список литературы
- Alberry M., Maddocks D., Jones M. et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblasts // Prenat. Diagn. - 2007. -Vol. 27. - P. 415-418.
- Avent N.D., Reid M.E. The Rh blood group system: a review // Blood. - 2000. - Vol. 95. - P. 375 - 387.
- Avent N.D. RhD genotyping from maternal plasma: guidelines and technical challenges // Methods Mol. Biol. - 2008. - Vol. 444. - P. 185 -201.
- Bianchi D.W., Zickwolf G.K., Weil G.J. et al. Male fetal progenitor cells persistin maternal blood for as long as 27 years postpartum // Proc. Nat. Acad. Sci USA. - 1996. -Vol. 93. - P. 705 -708.
- Chan K.C.A., Zhang J., Hui A.B. et al. Size distributions of maternal and fetal DNA in maternal plasma // Clin. Chem. -2004. - Vol. 50. - P. 88-92.
- Costa J.M., Benachi A., Gautier E. New strategy for prenatal diagnosis of X-linked disorders // N. Engl. J. Med. - 2002. -Vol. 346. - P. 1502.
- Chiu R.W.K., Lau T.K., Cheung P.T. et al. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study // Clin. Chem. - 2002. - Vol. 48. - P. 778-780.
- Di Renzo G.C., Rosati A., Sarti R.D. et al. Does fetal sex affect pregnancy outcome? // Gend. Med. - 2007. - Vol. 4. -P. 19-30.
- Dhallan R., Guo X., Emche S. et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study // Lancet. - 2007. - Vol. 10. -P. 474-481.
- Finning K.M., Chitty L.S. Non-invasive fetal sex determination: impact on clinical practice // Semin. Fetal. Neonatal Med. - 2008. - Vol. 13. - P. 69-75.
- Fan H.C., Blumenfeld Y.J., Chitkara U. et al. Analysis of the Size Distributions of Fetal and Maternal Cell-Free DNA by Paired-End Sequencing // Clin. Chem. - 2010. - Vol. 5. -P. 1279-1286.
- Finning K., Martin P., Summers J. et al. Effect of high throughput RhD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study // BMJ. - 2008. -Vol. 12. - P. 816-818.
- Finning K., Martin P., Daniels G. The use of maternal plasma for prenatal RhD blood group genotyping // Methods Mol. Biol. - 2009. - Vol. 49. - P. 143-157.
- Farina A., Sekizawa A., Rizzo N. et al. Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of PET to the collection of blood // Prenat. Diagn. - 2004. - Vol. 24. -P. 293-297.
- Geifman-Holtzman O., Ober Berman J. Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood // Expert. Rev. Mol. Diagn. - 2008. -Vol. 8, № 6. - P. 727-751.
- Human Genetics Commission. Choosing the future: genetics and reproductive decision making. July 2004.
- Hill M., Finning K., Martin P. et al. Non-invasive prenatal determination of fetal sex: translating research into clinical practice // Clin. Genet. - 2010. - Aug 19.
- Hill M., Taffinder S., Chitty L.S. et al. Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England // Prenat. Diagn. - 2011. -Vol. 31, № 3. - P. 267 - 255.
- Hall A., Bostanci A., Wright C.F. Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications // Public Health Genomics. - 2010. -Vol. 13, № 4. - P. 246-255.
- Hung E.C., Chiu R.W., Lo Y.M. Detection of circulating fetal nucleic acids: a review of methods and applications // J. Clin. Pathol. - 2009. - Vol. 62, № 4. - P. 308-313.
- Illanes S., Parra M., Serra R. et al. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction // Prenat. Diagn. - 2009. - Vol. 29, № 12. -P. 1118-1122.
- Ishihara N., Matsuo H., Murakoshi H. et al. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either PET or intrauterine growth retardation // Am. J Obstet. Gynecol. - 2002. - Vol. 86, № 1. -P. 158-166.
- Leung T.N., Lau T.K., Chung T.K. Thalassaemia screening in pregnancy // Curr. Opin. Obstet. Gynecol. - 2005. - Vol. 17, № 2. - P. 129-134.
- Leung T.N., Zhang J., Lau T.K. et al. Increased maternal plasma fetal DNA concentrations in women who eventually develop PET // Clin. Chem. - 2001. - Vol. 47. - P. 137-139.
- Lo Y.M., Leung T.N., Tein M.S. et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia // Clin. Chem. - 1999. - Vol. 45, № 2. - P. 184-188.
- Lo Y.M. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art // BJOG. - 2009. -Vol. 116, № 2. - P. 152-157.
- Lo Y.M.D., Corbetta N., Chamberlain P.F. et al. Presence of fetal DNA in maternal plasma and serum // Lancet. - 1997 -Vol. 350. - P. 485-487.
- Lo Y.M.D., Tein M.S., Lau T.K. et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis // Am. J. Hum. Genet. -1998. - Vol. 62. - P. 768-775.
- Masuzaki H., Miura K., Yoshiura K. et al. Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism // J. Med. Genet. - 2004. - Vol. 41. - P. 289 - 292.
- Melamed N., Yogev Y., Glezerman M. Fetal gender and pregnancy outcome // J. Matern. Fetal. Neonatal Med. -2010. - Vol. 23, № 4. - P. 338-344.
- Mujezinovic F., Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review // Obstet. Gynecol. - 2007. - Vol. 110, № 3. -P. 687-694.
- Masuzaki H., Miura K., Yoshiura et al. Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism // J. Med. Genet. - 2004. - Vol. 41. - P. 289 - 292.
- Pilgrim H., Lloyd-Jones M., Rees A. Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation // Health Techno l. Assess. - 2009. - Vol. 13, № 10. - P. 100-103.
- Ren C.C., Miao X.H., Cheng H. et al. Detection of fetal sex in the peripheral blood of pregnant women // Fetal. Diagn. Ther. - 2007. - Vol. 22, № 5. - P. 377-382.
- Rijnders R.J., van der Luijt R.B., Peters E.D. et al. Earliest gestational age for fetal sexing in cell-free maternal plasma // Prenat. Diagn. - 2003. - Vol. 23. -P. 1042-1044.
- Schmorl G. Pathologische-anatomische Untersuchungen uber Puerperal-Eklampsie. Leipzig: Vogel 1893.
- Sifakis S., Zaravinos A., Maiz N. et al. First-trimester maternal plasma cell-free fetal DNA and preeclampsia // Am. J. Obstet. Gynecol. - 2009. - Vol. 201, № 5. - P. 472-477.
- Timmerman E., Pajkrt E., Bilardo C.M. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency // Ultrasound Obstet. Gynecol. - 2009. - Vol. 34, № 4. - P. 373-378.
- Tong Y.K., Chiu R.W., Leung T.Y. et al. Detection of restriction enzyme-digested target DNA by PCR amplification using a stem-loop primer: application to the detection of hypomethylated fetal DNA in maternal plasma // Clin. Chem. - 2007. - Vol. 53, № 11. - P. 1906-1914.
- Wataganara T., Gratacos E., Jani J. et al. Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twintwin transfusion syndrome // Am. J. Obstet. Gynecol. - 2005. - Vol. 192. -P. 604-609.
- Wright C.F., Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis // Hum. Reprod. Update. - 2009. - Vol. 5, № 1. - P. 139-151.
- Zhong X.Y., Holzgreve W., Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of PET // Hypertens Pregnancy. - 2002. -Vol. 21. - P. 77-83.
- Zhong X.Y., Laivuori H., Livingston J.C. et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with PET // Am. J. Obstet. Gynecol. - 2001. - Vol. 184. -P. 414-419.